XT
CATX icon

XTX Topco’s Perspective Therapeutics CATX Stock Holding History

XTX Topco’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+31,600
New +$119K ﹤0.01% 3508
2026
Q1 		– Sell
-82,476
Closed -$227K – 3881
2025
Q4 		$227K Buy
82,476
+22,074
+37% +$63K 0.01% 2301
2025
Q3 		$207K Buy
+60,402
New +$220K 0.01% 1820
2025
Q1 		– Sell
-18,070
Closed -$57.6K – 2471
2024
Q4 		$57.6K Sell
18,070
-19,230
-52% -$157K ﹤0.01% 1874
2024
Q3 		$498K Buy
+37,300
New +$496K 0.04% 821

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

XTX Topco's CATX Position: Q2 2026 in Review

XTX Topco opened a new position in Perspective Therapeutics (CATX) in Q2 2026: 31,600 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3508 among its holdings. This is a return to the name: XTX Topco previously reported a position in CATX as recently as Q4 2025.

XTX Topco first reported a position in CATX in Q3 2024 and has held it in 5 quarters since. The position peaked at $498K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • XTX Topco held 31,600 shares of Perspective Therapeutics worth $108K as of Q2 2026.
  • Perspective Therapeutics was a new XTX Topco position in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3508 holding.
  • XTX Topco first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • XTX Topco's Perspective Therapeutics position peaked at $498K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.